Skip to content

Individualized and High-Dose Transcranial Electrical Stimulation for the Treament of Insomnia Disorders: a Randomized Double-Blind Controlled Study

Individualized and High-Dose Transcranial Electrical Stimulation for the Treament of Insomnia Disorders: a Randomized Double-Blind Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100986
Enrollment
Unknown
Registered
2025-04-17
Start date
2024-11-19
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Disorder

Interventions

Active tDCS group:Individualized and high-dose transcranial direct current stimulation (tDCS)
Sham tDCS group:None

Sponsors

Shanghai Yangzhi rehabilitation hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Agree to sign the informed consent form; 2. Promise to abide by the research procedures and cooperate with the implementation of the whole process of research; 3. Age 18-75 years old; 4. Diagnosis of chronic insomnia (according to DSM-5 criteria); 5. Have the ability to take care of themselves and have no drug abuse; 6. Have not received ECT, rTMS, tES therapy, or cognitive behavioral therapy for insomnia within 8 weeks prior to enrollment; 7. If the patient is taking sedative-hypnotic drugs, there is no drug type and dose adjustment within 8 weeks before enrollment

Exclusion criteria

Exclusion criteria: 1. Previous or current diagnosis of other diseases other than insomnia, anxiety disorders and depressive disorders in DSM-5; 2. Severe anxiety or depressed mood (HAMD-17>23 points or HAMA>30 points); 3. Patients with severe obstructive sleep apnea syndrome; 4. Patients with severe migraine who have migraine attacks for two consecutive months >=4 times/month; 5. Serious physical illness and any physical disease that can induce epilepsy or intracranial hypertension, including cardiovascular and respiratory diseases; 6. History of neurological diseases (such as epilepsy, cerebrovascular accident, etc.) or traumatic brain injury or brain surgery; 7. Intracranial stents, pacemakers, coronary stents, cochlear implants and other human implantable materials are installed; 8. Having serious negative thoughts or a high risk of suicide; 9. Women who are pregnant or have recently tried to become pregnant.

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index;Hamilton Anxiety Rating Scale;Hamilton Depression Rating Scale;Beck Depression Inventory, BDI-II;Beck Anxiety Inventory;Treatment response;Treatment remission;Subjective Sleep Quality;Objective Sleep Quality;Objective Sleep Quality in home;Side effects scale;Epworth Sleepiness Scale;

Countries

China

Contacts

Public ContactDanmei Lan

Shanghai Yangzhi rehabilitation hospital

landanmei2013@163.com+86 18521308136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026